Navigation Links
Lilly Reports Fourth-Quarter and Full-Year 2009 Results
Date:1/28/2010

and administrative expenses, grew 12 percent compared with the fourth quarter of 2008. Operating income decreased 10 percent to $1.333 billion, due to lower gross margins. Excluding the impact of changes in foreign exchange rates, operating income would have increased approximately 15 percent. Other income (expense) improved $41.5 million to a net expense of $67.8 million. The effective tax rate was 21 percent, up from 19.1 percent in the fourth quarter of 2008. Net income and earnings per share decreased 10 percent and 11 percent respectively. Excluding the impact of changes in foreign exchange rates, earnings per share would have increased approximately 16 percent.

Fourth-Quarter Significant Items Affecting Reported Net Income

The reported results for the fourth quarters of 2009 and 2008 were affected by significant items totaling $.08 per share and $4.38 per share, respectively. To reflect the impact of the ImClone acquisition as if the acquisition occurred on January 1, 2008, fourth quarter 2008 pro forma earnings per share have been reduced by $.05 per share. For further detail, see the reconciliation below as well as the footnotes to the pro forma non-GAAP income statement later in this press release.

    
    
    
                                                    Fourth Quarter
                                                    --------------
                                                    2009      2008  % Growth
                                                    ----      ----  --------
    
    Earnings (loss) per share (reported)            $.83    $(3.31)    NM
    Tax benefit associated with EDPA settlement        -      (.13)
    Asset impairments and restructuring charges      .02       .05
   
'/>"/>
SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
3. Lilly and Glenmark Pharmaceuticals Announce License Agreement
4. Lilly Receives NCQA Design Certification for Depression Care Management Program
5. JDRF and Lilly Partner to Fund Research to Identify Beta Cell Biomarkers
6. FDA Grants Priority Review for Daiichi Sankyo, Lilly Drug, prasugrel
7. Statement from Eli Lilly and Company: Response to Connecticut Attorney General News Release
8. Lilly and Transition Therapeutics Announce Licensing and Collaboration Agreement
9. Lilly Launches Its First Phase III Trial for Treatment of Alzheimers Disease
10. Daiichi Sankyo/Eli Lillys Effient and Astrazenecas Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction
11. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2015)... , Feb. 26, 2015  Spring Bank Pharmaceuticals, ... for the treatment of Hepatitis B virus (HBV) ... of a $22 million financing. Funds from this ... a novel, broad spectrum antiviral agent derived from ... hybrid (SMNH) chemistry platform, into Phase II clinical ...
(Date:2/26/2015)... 2015  Lyric Pharmaceuticals Inc. today announced the initial ... million. The financing, co-led by RiverVest Venture Partners, Sante ... Venture Partners. Lyric is a clinical-stage ... , M.D., M.B.A., President & Chief Executive Officer and ... In 2014, Lyric closed a seed financing round of ...
(Date:2/26/2015)... 2015  CSSi, ( www.CSSiEnroll.com ) the leader ... industry, is pleased to announce the recent appointment ... Manager, adding significant value and expertise to our ... Karen is an accomplished, ... successfully lead the navigation of the program life ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Completes $22 Million Financing 2CSSi's Continued Growth Brings Talented New Hire - Karen Welch Welcomed as Project Manager 2
... IDM Pharma, Inc.,(Nasdaq: IDMI ) today ... for Medicinal Products for Human Use (CHMP) and ... 25th, following the,CHMP,s September meeting where CHMP considered ... for the,treatment of patients with non-metastatic, resectable osteosarcoma, ...
... Preventing Possibly Life-Threatening,Condition During Air Travel, ALEXANDRIA, ... (APTA) supports the recent "Call to Action" by,Acting ... reduce the number of,cases of deep vein thrombosis ... According to Susan Scherer, PT, PhD, associate professor ...
Cached Medicine Technology:IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 2IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 3IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 4IDM Pharma Provides Update on Mifamurtide (L-MTP-PE) Regulatory Status Following September Meeting of European Committee for Medicinal Products for Human Use (CHMP) 5APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism 2APTA Supports Surgeon General's 'Call to Action' to Prevent Deep Vein Thrombosis and Pulmonary Embolism 3
(Date:2/27/2015)... The Radiology Business Management Association ... class of Fellows — one of the most highly ... , Since 2009, the RBMA Fellowship program has ... members to the Association and the profession. Fellow of ... Fellow candidate must meet a very high standard for ...
(Date:2/27/2015)... Leading massage chair retailer Emassagechair.com is known ... month they take a look at leading issues and help ... In the month of March they will be recognizing National ... by bringing awareness to the time change that occurs as ... start on March 2nd, and last until March 8th when ...
(Date:2/27/2015)... to a Feb. 12, 2015 news release by Verastem, ... by killing cancer stem cells, has received orphan drug designation ... in the treatment of mesothelioma.* According to the release, orphan ... development of drugs for the treatment of rare diseases. ... Melinda Helbock, Founder of The Law Office of Melinda J. ...
(Date:2/27/2015)... Atlanta, GA (PRWEB) February 27, 2015 ... firm, Martin Ventures, is collaborating with the Atlanta-based ... accelerate the adoption of Jvion’s advanced predictive capabilities ... predictive analytics company that identifies and prevents financial ... growing need for predictions that help prevent patient ...
(Date:2/27/2015)... Santa Cruz, CA (PRWEB) February 27, 2015 ... Opal Gas Processing Plant in Lincoln County, Wyoming. ... the area in preparation for interstate natural gas pipeline ... the natural gas., The Opal plant initially began operations ... expansions to serve growing natural gas production in Wyoming. ...
Breaking Medicine News(10 mins):Health News:RBMA Issues Call for Fellowship Applicants 2Health News:Emassagechair Wants Shoppers to Think About the Benefits of Massage During National Sleep Awareness Week 2Health News:Emassagechair Wants Shoppers to Think About the Benefits of Massage During National Sleep Awareness Week 3Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 2Health News:New Drug Receives FDA Approval as Orphan Drug for the Treatment of Mesothelioma 3Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 2Health News:Jvion Gains Strategic Collaboration Partner in Martin Ventures 3Health News:Clean Water Systems Supplies Advanced Chlorine Disinfection Skid for Wyoming Gas Plant 2
... by the bird flu threat has resulted in poultry products ... capital. One can see that in Gazipur wholesale market chickens ... ,Only those chickens that were certified by the veterinary ... whereas those that were uncertified was available for a mere ...
... blood samples, taken from the people of Nandurbar district, is ... virus had spread to humans, even as the culling of ... ,Officials said the massive culling exercise in the region that ... to be completed by early Thursday. ,India's first ...
... ever-cervical cancer vaccine, Gardasil is expected to be launched ... 24 years of age. // Soon, men might also ... infecting their sexual partners and to protect themselves against ... under experimental phase, for demonstration of cervical cancer prevention. ...
... announced the approval of a new antifungal drug, for ... new drug called Eraxis, // is indicated in the ... ,The improved performance of Eraxis compared to ... have supported the approval. The drug can also be ...
... health problem of having too many ailing hearts, making it ... the bloc’s members, a whopping 169 billion euros in 2003, ... look at the annual statistics, but watch your heart before ... 230 euros on an average on Healthcare costs, per person. ...
... Inc. (OTCBB:MDLH) Needle– Free Injection System, designed specifically to ... toward establishing itself as a valuable instrument in the ... animals. With its patented ability to adjust pressure and ... the Company in a unique situation especially should there ...
Cached Medicine News:Health News:Delhi Sees Sharp Decline In Chicken Prices 2Health News:Delhi Sees Sharp Decline In Chicken Prices 3Health News:India Awaits Test Results To Confirm The Bird Flu Virus In Humans 2Health News:Men Might Get Their Share of Cervical Cancer Vaccine As Well 2Health News:Needle-Free Injection System Ideal for Pandemic Outbreaks 2Health News:Needle-Free Injection System Ideal for Pandemic Outbreaks 3
... difficile Panel is an enzyme immunoassay used ... antigen (glutamate dehydrogenase) and toxin A in ... as an aid in the diagnosis of ... of the Triage Microbiology product line, designed ...
ELISA for the detection of C. difficile toxin A in stool specimens...
... CCD cameras provide fast, accurate, reliable and ... quality at an excellent price. , , ... TOMEY TR-4000 Auto Refractor provides highly accurate ... is obtained simply by pushing a button. ...
... SP-3000 covers all needs regarding pachymetry in ... care., ,Compact design, colored touch-screen and "quick ... an "easy-to-use unit.,The wide measurement range from ... the possibility to measure very thin or ...
Medicine Products: